Medical News

RSS

Potential new therapeutic option for prevention of PD-associated neuropathology

Scientists have identified a synergistic interaction that disrupts normal intracellular transport mechanisms and leads to the accumulation of neuron-damaging clumps of protein associated with Parkinson's disease (PD), a neurodegenerative disorder that is characterized by a specific loss of neurons in the midbrain and brainstem. The research, published by Cell Press in the December 24 issue of the journal Neuron, identifies a new potential therapeutic option for preventing PD-associated neuropathology.

24 Dec 2009

Tips to minimize injuries during winter season

As we try to get outside and make the most of these cold winter months, it's important to use basic safety tips that help minimize injury. The Minnesota Chiropractic Association (MCA) offers the following tips to help keep your family injury free.

24 Dec 2009

Stem Cell Therapy International-Histostem merger on schedule

Stem Cell Therapy International, Inc. announced that its pre-closing conditions for its merger with Histostem Co. Ltd. ("Histostem") are proceeding on schedule with an expected close of the merger in January 2010.

24 Dec 2009

Transcend Services closes public offering of common stock

TRANSCEND SERVICES, INC. (the “Company”) today announced the December 22, 2009 closing of the public offering of a total of 2,553,000 shares of its common stock at a price to the public of $16.75 per share. The Company sold 1,725,000 shares and the selling stockholders sold 828,000 shares.

24 Dec 2009

Drug companies winners of the American prescription drug debate

On Dec. 15, the Obama Administration rejected a plan to allow the wholesale reimportation of cheaper prescriptions drugs from abroad, despite projected intentions to take on the drug industry and secure cheaper prescription for Americans.

24 Dec 2009

Study evaluates anemia treatment approaches adopted by different specialists

BioTrends Research Group, Inc. published a syndicated research report, "TreatmentTrends®: Anemia in the United States," based on primary research conducted with approximately 400 physicians in clinical practice.

24 Dec 2009

Retractable Technologies wins patent infringement suit

Retractable Technologies, Inc. (“Retractable”) (AMEX: RVP), a leading maker of safety needle devices, announced today that a Tyler, Texas jury returned a verdict on Friday, December 18th in the litigation of Retractable Technologies, Inc. v. OMI (Occupational & Medical Innovations Limited, an Australian public company,) in favor of Retractable on all claims presented to the jury.

24 Dec 2009

Unigene Laboratories files shelf registration statement with Securities and Exchange Commission

Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene.com) announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (“SEC”).

24 Dec 2009

Changes in sleep patterns predict onset of puberty, says new study

Are your 11- and 12-year-olds staying up later, then dozing off at school the next day? Parents and educators who notice poor sleeping patterns in their children should take note of new research from Tel Aviv University ― and prepare themselves for bigger changes to come.

24 Dec 2009

Raptor Pharmaceutical completes $7.5 million registered direct offering

Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced that on December 22, 2009, it completed its registered direct offering with institutional investors, raising an aggregate amount of approximately $7.5 million of gross proceeds (before placement agent fees and offering expenses) through the sale of 3,747,558 units.

24 Dec 2009

Orexigen Therapeutics' Compensation Committee approves inducement grants

Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.

24 Dec 2009

Union Bank and AHA announce new sponsorship agreement

Union Bank, N.A., and The American Heart Association (AHA) have announced a four-year agreement to promote the AHA’s Start! movement in Los Angeles, Orange, and San Diego counties.

24 Dec 2009

Colcrys Patient Assistance Program introduced by URL Pharma

URL Pharma, Inc. announced the launch of the Colcrys® (colchicine, USP) Patient Assistance Program, an initiative that will allow patients with limited means to save on Colcrys prescriptions. This program reflects URL Pharma's ongoing commitment to helping ensure that all patients who rely on the company's medications are able to access them, regardless of economic status. Colcrys is indicated for the prevention and treatment of gout flares and for the treatment of Familial Mediterranean Fever (FMF).

24 Dec 2009

Rethink Autism offers research-based intervention tools for children with autism disorder

According to a study recently released by the Center for Disease Control and Prevention (CDC) and the Autism and Developmental Disabilities Monitoring Network, it is estimated that approximately 673,000 children aged 3-21 have been diagnosed with autism nationwide.

24 Dec 2009

LUHS urogynecologists awarded $1M NIH Challenge Grant

The National Institutes of Health (NIH) has awarded a Challenge Grant for $1 million to Loyola University Health System (LUHS) urogynecologists Kimberly Kenton, MD, and Elizabeth Mueller, MD. This places them among the top 2 percent of researchers in the nation to receive this grant.

24 Dec 2009

NPAF impressed with progress on health care reform

The National Patient Advocate Foundation (NPAF) - a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels - today praised Senate leadership for their tireless work on historic health care reform, and encouraged lawmakers to continue their steadfast work on this important issue in the weeks to come.

24 Dec 2009

FRC Action launches campaign to protest Senate health care bill

As the Senate prepares for a Christmas Eve vote on Senator Reid's health care bill, Family Research Council Action (FRC Action) announced that it will immediately begin a last minute phone call campaign in six states -- Nebraska, Arkansas, Louisiana, South Dakota, Pennsylvania, and Virginia. The phone calls will ask voters to contact their Senators and tell them "don't trade the lives of children for political power."

24 Dec 2009

National Council on Aging favors Senate health reform bill

The National Council on Aging supports the Senate for its Patient Protection and Affordable Care Act (H.R. 3590), which, when passed, will bring America one giant step closer to the long-awaited goal of health care that is both accessible and affordable for Americans of all ages.

24 Dec 2009

Forest Laboratories acquires additional rights to NXL 104 beta-lactamase inhibitor

Forest Laboratories announced today its agreement to acquire additional rights to NXL 104, which amends the terms of its prior agreement with Novexel covering the combination of NXL 104 with ceftaroline and adds additional rights to the combination of ceftazidime and NXL 104, through a transaction with AstraZeneca executed immediately following AstraZeneca’s announced acquisition of Novexel, S.A.

24 Dec 2009

Researchers unveil complete genetic make-up of cavity-causing bacterium

Researchers have uncovered the complete genetic make-up of the cavity-causing bacterium Bifidobacterium dentium Bd1, revealing the genetic adaptations that allow this microorganism to live and cause decay in the human oral cavity.

24 Dec 2009